C-Rad AB (publ) (CRAD-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.205x

Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) has a cash flow conversion efficiency ratio of 0.205x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr71.10 Million ≈ $7.65 Million USD) by net assets (Skr347.20 Million ≈ $37.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of C-Rad AB (publ) to measure how much of total assets are equity-financed.

C-Rad AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how C-Rad AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check C-Rad AB (publ) cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

C-Rad AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of C-Rad AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Li-FT Power Ltd.
F:WS0
-0.002x
Impiana Hotels Bhd
KLSE:7243
-0.032x
LIWANLI Innovation Co Ltd
TW:3054
-0.056x
OM Holdings Ltd
KLSE:5298
-0.004x
Merit Turizm Yatirim ve Isletme AS
IS:MERIT
0.006x
Humanica Public Company Limited
BK:HUMAN
0.044x
Jeld-Wen Holding Inc
NYSE:JELD
0.098x
Hunter Group ASA
OL:HUNT
-0.134x

Annual Cash Flow Conversion Efficiency for C-Rad AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of C-Rad AB (publ) from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see CRAD-B stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr347.20 Million
≈ $37.36 Million
Skr71.10 Million
≈ $7.65 Million
0.205x +121.28%
2024-12-31 Skr324.99 Million
≈ $34.97 Million
Skr30.08 Million
≈ $3.24 Million
0.093x -21.94%
2023-12-31 Skr281.60 Million
≈ $30.30 Million
Skr33.38 Million
≈ $3.59 Million
0.119x +196.73%
2022-12-31 Skr242.54 Million
≈ $26.10 Million
Skr9.69 Million
≈ $1.04 Million
0.040x -49.18%
2021-12-31 Skr231.09 Million
≈ $24.87 Million
Skr18.17 Million
≈ $1.96 Million
0.079x -14.85%
2020-12-31 Skr199.79 Million
≈ $21.50 Million
Skr18.45 Million
≈ $1.99 Million
0.092x -51.38%
2019-12-31 Skr83.33 Million
≈ $8.97 Million
Skr15.83 Million
≈ $1.70 Million
0.190x +285.14%
2018-12-31 Skr93.64 Million
≈ $10.08 Million
Skr-9.61 Million
≈ $-1.03 Million
-0.103x -82.21%
2017-12-31 Skr71.41 Million
≈ $7.68 Million
Skr-4.02 Million
≈ $-432.62K
-0.056x +91.09%
2016-12-31 Skr70.60 Million
≈ $7.60 Million
Skr-44.62 Million
≈ $-4.80 Million
-0.632x -10.29%
2015-12-31 Skr40.05 Million
≈ $4.31 Million
Skr-22.95 Million
≈ $-2.47 Million
-0.573x -38.13%
2014-12-31 Skr40.04 Million
≈ $4.31 Million
Skr-16.61 Million
≈ $-1.79 Million
-0.415x +30.97%
2013-12-31 Skr38.03 Million
≈ $4.09 Million
Skr-22.86 Million
≈ $-2.46 Million
-0.601x +25.17%
2012-12-31 Skr16.26 Million
≈ $1.75 Million
Skr-13.06 Million
≈ $-1.41 Million
-0.803x -41.62%
2011-12-31 Skr36.02 Million
≈ $3.88 Million
Skr-20.43 Million
≈ $-2.20 Million
-0.567x -444.26%
2010-12-31 Skr48.12 Million
≈ $5.18 Million
Skr-5.01 Million
≈ $-539.60K
-0.104x +64.39%
2009-12-31 Skr29.82 Million
≈ $3.21 Million
Skr-8.73 Million
≈ $-939.06K
-0.293x -2.01%
2008-12-31 Skr35.05 Million
≈ $3.77 Million
Skr-10.06 Million
≈ $-1.08 Million
-0.287x --

About C-Rad AB (publ)

ST:CRAD-B Sweden Medical Devices
Market Cap
$123.07 Million
Skr1.14 Billion SEK
Market Cap Rank
#18350 Global
#316 in Sweden
Share Price
Skr35.60
Change (1 day)
-3.00%
52-Week Range
Skr24.90 - Skr38.80
All Time High
Skr66.70
About

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more